長青集團(002616.SZ):2023年度暫沒收到新的補貼發放
格隆匯7月13日丨長青集團(002616.SZ)近期在接待機構投資者調研時表示,公司登記在“可再生能源電價附加補助資金目錄”上的生物質發電項目於去年下半年收到國家按2022年預算撥付的第一次補貼,2023年度暫沒收到新的補貼發放。具體到行業及項目可獲取的金額以當年財政部公佈的可再生能源補貼總額為準。正是為了應對補貼發放的不及時,公司未來重點發展的還是生物質熱電聯產、以非電收入為主這個方向,以降低對補貼的依賴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.